<section class="app-company-leadership">
    <div class="app-container --lg">
        <h2 class="app-section-title">Our Leadership</h2>
        <div class="app-company-leader">
            <div class="--image">
                <img src="./images/andy-cowen.jpg" alt="Andy Cowen" title="Andy Cowen" />
            </div>
            <div class="--body">
                <div class="--header">
                    <div class="--person-name">Andy Cowen</div>
                    <div class="--person-position">Chief Executive Officer</div>
                </div>
                <div class="--content">
                    <p>Andy serves as Chief Executive Officer of Radialogica and has over twenty-five years of executive
                        leadership and private equity investment experience in the healthcare industry. He previously served
                        as President and Chief Executive Officer of CMS, Inc., the radiotherapy treatment planning company,
                        where he led the successful strategic repositioning and operational restructuring of the business and
                        subsequent sale to Elekta AB. Prior to joining CMS he served for twelve years as an executive of
                        Brown Brothers Harriman in its private equity investment group, with primary responsibility for Brown
                        Brothers' healthcare-oriented venture and growth capital investments. Andy is a Phi Beta Kappa and
                        summa cum laude graduate of Bowdoin College and earned his MBA from the Wharton School of the
                        University of Pennsylvania.</p>
                </div>
            </div>
        </div>
        <div class="app-company-leader">
            <div class="--image">
                <img src="./images/scott-brame.jpg" alt="Scott Brame, PhD" title="Scott Brame, PhD" />
            </div>
            <div class="--body">
                <div class="--header">
                    <div class="--person-name">Scott Brame, PhD</div>
                    <div class="--person-position">Chief Operating Officer</div>
                </div>
                <div class="--content">
                    <p>Scott serves as Chief Operating Officer of Radialogica with responsibility for research and product
                        development and service delivery. He previously served as Chief of Clinical Development in the
                        Department of Radiation Oncology at the Washington University School of Medicine and Siteman
                        Cancer Center. Prior to joining the faculty at Washington University, he served as Senior Vice
                        President of Clinical Design and Research at CMS, Inc., before which he was a Research Fellow at
                        the Memorial Sloan-Kettering Cancer Center in New York City. Scott's research interests focus on the
                        application of Bayesian statistics and decision theory to problems in Oncology. He received his
                        Ph.D. from the University of Tennessee and his MBA from the Olin School of Business at Washington
                        University in St. Louis.</p>
                </div>
            </div>
        </div>
        <div class="app-company-leader">
            <div class="--image">
                <img src="./images/cliff-robinson.jpg" alt="Cliff Robinson, MD" title="Cliff Robinson, MD" />
            </div>
            <div class="--body">
                <div class="--header">
                    <div class="--person-name">Cliff Robinson, MD</div>
                    <div class="--person-position">Chief Medical Officer</div>
                </div>
                <div class="--content">
                    <p>Dr. Robinson is a Professor of Radiation Oncology and Cardiology at Washington University in St.
                        Louis. He holds several leadership roles, including Associate Director of Clinical Programs, Medical
                        Director of Radiation Oncology Clinical Research, Chief of the Cardiothoracic and Stereotactic Body
                        Radiotherapy services, and Co-Director of the Center for Noninvasive Cardiac Radiotherapy. Dr.
                        Robinson has established research interests developing and standardizing advanced radiotherapy
                        technologies and novel drug combinations, promoting and codifying multi-disciplinary care and
                        patient-centered decision making, and developing and testing new indications for radiotherapy. He is
                        a Principal investigator for the international randomized PACIFIC-4 trial examining SBRT with or
                        without immunotherapy for early stage lung cancer, a multi-center NIH R01 funded trial examining
                        patient-centered decision making for early stage lung cancer, and an NIH U54 center grant exploring
                        tumor microenvironment effects after radiotherapy. He is also a key developer of the recently
                        opened pivotal randomized Varian sponsored RADIATE-VT trial comparing cardiac radioablation to
                        repeat catheter ablation for patients with high risk refractory ventricular tachycardia.</p>
                </div>
            </div>
        </div>

        <h2 class="app-section-title">Medical Advisory Board</h2>
        <div class="app-company-leader">
            <div class="--image"></div>
            <div class="--body">
                <div class="--header">
                    <div class="--person-name">Kiran Devisetty, MD</div>
                    <div class="--person-position">Board Member</div>
                </div>
                <div class="--content">
                    <p>Kiran is a Senior Director of Clinical Development, Interventional Oncology at Johnson & Johnson
                        where he leads the design, execution, and oversight of the clinical development strategy for J&J'sP
                        hase 1, 2, and 3 trials. He also serves as a Radiation Oncologist with the U.S. Department of Veterans
                        Affairs at the VA Philadelphia Healthcare System.</p>
                </div>
            </div>
        </div>
        <div class="app-company-leader">
            <div class="--image">
                <img src="./images/salma-jabbour.jpg" alt="Salma Jabbour, MD" title="Salma Jabbour, MD" />
            </div>
            <div class="--body">
                <div class="--header">
                    <div class="--person-name">Salma Jabbour, MD</div>
                    <div class="--person-position">Board Member</div>
                </div>
                <div class="--content">
                    <p>Dr. Salma Jabbour is Professor, Vice Chair of Clinical Research and Faculty Development in
                        Radiation Oncology, and Associate Director of Faculty Affairs and Development at the Rutgers
                        Cancer Institute of New Jersey. She leads the Radiation Oncology Disease Specific Group. Dr.
                        Jabbour's clinical practice and research focus on lung cancers and gastrointestinal malignancies
                        and she is the Lead Thoracic and GI Radiation Oncologist. Dr. Jabbour's clinical research resulted in
                        many influential publications in major journals. She has authored over 230 articles and numerous
                        book chapters and monographs. She served previously as the Senior Editor for the International
                        Journal of Radiation Oncology, Biology and Physics (IJROBP) and Deputy Editor of the IJROBP. She
                        participates in multiple ASTRO committees and was selected as Fellow of ASTRO. She also
                        participates in the Big Ten Cancer Research Consortium Steering Committee and is Chair of the
                        Scientific Review Board at the Rutgers Cancer Institute as well as Leader of the Radiation Oncology
                        Disease Specific Group which she founded. Dr. Jabbour leads and participates in many pivotal
                        clinical trials involving combinations of systemic therapy and radiation therapy. She is the Principal
                        Investigator of international studies including KeyNote-799. She is an NIH funded researcher and has
                        mentored over 100 trainees and faculty.</p>
                </div>
            </div>
        </div>
        <div class="app-company-leader">
            <div class="--image">
                <img src="./images/tim-kruser.jpg" alt="Tim Kruser, MD" title="Tim Kruser, MD" />
            </div>
            <div class="--body">
                <div class="--header">
                    <div class="--person-name">Tim Kruser, MD</div>
                    <div class="--person-position">Board Member</div>
                </div>
                <div class="--content">
                    <p>Dr. Kruser is a radiation oncologist who practices in Madison, Wi with a focus on central nervous
                        system tumors as well as lung, head and neck, and genitourinary malignancies. He was previously an
                        Assistant Professor and the Director of Stereotactic Radiation at Northwestern Memorial Hospital in
                        Chicago, where his research focused on clinical trial development in benign and malignant brain
                        tumors, brain metastases, and lung cancer. He has established expertise in radiation quality
                        assurance, and in that vein currently serves as the radiation oncology chair of NRG Oncology BN011,
                        a national randomized trial in glioblastoma, as well as radiation oncology co-chair of NRG Oncology
                        BN003, a randomized examination of postoperative radiation in meningioma.</p>
                </div>
            </div>
        </div>

    </div>
</section>